Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Enliven Therapeutics, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 134
- +9 vs. Q2 2025
- Shares held
- 59.4M
- −34.8K (−0.1%) vs. Q2 2025
- Total value
- $1.22B
- +$23.4M (+2.0%) vs. Q2 2025
- New holders
- 20
- 59 more added
- Sold out
- 11
- 32 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Morgan Stanley | 258,384 | $5.29M | 0.00% | +3,536+1.4% | Added |
| HighVista Strategies LLC | 259,135 | $5.30M | 1.30% | +117,619+83.1% | Added |
| Goldman Sachs Group Inc | 262,272 | $5.37M | 0.00% | +72,767+38.4% | Added |
| Woodline Partners LP | 300,499 | $6.15M | 0.03% | −800,158−72.7% | Reduced |
| Logos Global Management LP | 340,000 | $6.96M | 0.69% | −10,000−2.9% | Reduced |
| Marshall Wace, LLP | 340,482 | $6.97M | 0.01% | +7,149+2.1% | Added |
| Charles Schwab Investment Management Inc | 363,202 | $7.43M | 0.00% | +57,542+18.8% | Added |
| Millennium Management LLC | 381,405 | $7.81M | 0.01% | +62,956+19.8% | Added |
| Northern Trust Corp | 394,452 | $8.07M | 0.00% | +69,824+21.5% | Added |
| Affinity Asset Advisors, LLC | 400,000 | $8.19M | 0.76% | 00.0% | Unchanged |
| Franklin Resources Inc | 430,240 | $8.81M | 0.00% | 00.0% | Unchanged |
| Candriam Luxembourg S.C.A. | 609,352 | $12.5M | 0.07% | +192,702+46.3% | Added |
| Rock Springs Capital Management LP | 686,107 | $14.0M | 0.82% | −15,301−2.2% | Reduced |
| 5AM Venture Management, LLC | 772,477 | $15.8M | 5.79% | 00.0% | Unchanged |
| First Turn Management, LLC | 783,411 | $16.0M | 2.41% | +273,424+53.6% | Added |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 947,405 | $19.4M | 0.49% | +484,405+104.6% | Added |
| State Street Corp | 965,137 | $19.8M | 0.00% | +148,895+18.2% | Added |
| Point72 Asset Management, L.P. | 1,040,410 | $21.3M | 0.05% | −312,668−23.1% | Reduced |
| Geode Capital Management, LLC | 1,085,013 | $22.2M | 0.00% | +202,260+22.9% | Added |
| Vestal Point Capital, LP | 1,160,000 | $23.7M | 1.08% | +910,000+364.0% | Added |
| Citadel Advisors LLC | 1,160,503 | $23.8M | 0.02% | −309,921−21.1% | Reduced |
| Capital Research Global Investors | 1,315,465 | $26.9M | 0.01% | 00.0% | Unchanged |
| Blackstone Group Inc. | 1,320,592 | $27.0M | 0.12% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 1,398,087 | $28.6M | 0.03% | +430,585+44.5% | Added |
| Novo Holdings A/S | 1,426,260 | $29.2M | 1.88% | +341,828+31.5% | Added |
| Janus Henderson Group PLC | 1,793,583 | $36.7M | 0.02% | +77,171+4.5% | Added |
| Vanguard Group Inc | 2,553,014 | $52.3M | 0.00% | +142,378+5.9% | Added |
| Polar Capital Holdings Plc | 3,095,007 | $63.4M | 0.31% | +44,713+1.5% | Added |
| VR Adviser, LLC | 3,226,331 | $66.0M | 3.72% | −800,000−19.9% | Reduced |
| BlackRock, Inc. | 3,518,524 | $72.0M | 0.00% | +551,390+18.6% | Added |
| Fairmount Funds Management LLC | 3,711,444 | $76.0M | 6.84% | 00.0% | Unchanged |
| Commodore Capital LP | 4,692,809 | $96.1M | 4.69% | 00.0% | Unchanged |
| FMR LLC | 7,129,196 | $145.9M | 0.01% | −430,705−5.7% | Reduced |
| OrbiMed Advisors LLC | 7,959,538 | $162.9M | 3.91% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −848,986−100.0% | Sold out |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −498,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −281,394−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −56,981−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −47,622−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −28,584−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −28,334−100.0% | Sold out |
| Voloridge Investment Management, LLC | 0 | $0 | 0.00% | −17,656−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −1,536−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | 0 | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −38−100.0% | Sold out |